ctrl K

Aspire BioPharma Inc. (ASBP)

NASDAQ: ASBP · Real-Time Price · USD

0.37

-0.05 (-12.74%)

At close: May 01, 2025, 3:59 PM

0.38

3.29%

After-hours: May 01, 2025, 07:51 PM EDT

Aspire BioPharma Income Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	FY 2023	FY 2022
Period Ending	Dec 31, 2023	Dec 31, 2022
Revenue	n/a	n/a
Cost of Revenue	n/a	n/a
Gross Profit	n/a	n/a
Operating Income	-358.59K	-596.49K
Interest Income	n/a	n/a
Pretax Income	-358.59K	-596.49K
Net Income	-359.07K	-597.12K
Selling & General & Admin	286.54K	421.18K
Research & Development	72.05K	175.32K
Other Expenses	n/a	n/a
Operating Expenses	358.59K	596.49K
Interest Expense	n/a	n/a
Selling & Marketing Expenses	39.64K	45.48K
Cost & Expenses	358.59K	596.49K
Income Tax Expense	481.00	626.00
Shares Outstanding (Basic)	45.94M	45.94M
Shares Outstanding (Diluted)	45.94M	45.94M
EPS (Basic)	-0.01	-0.01
EPS (Diluted)	-0.01	-0.01
EBITDA	n/a	-596.49K
EBIT	-358.59K	-596.49K
Depreciation & Amortization	n/a	n/a